Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. SLP
SLP logo

SLP Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Simulations Plus Inc (SLP) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
12.470
1 Day change
1.71%
52 Week Range
36.450
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Simulations Plus Inc (SLP) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock faces significant headwinds, including insider selling, muted growth outlook, and limited recovery visibility. While there are some positive financial metrics, the overall sentiment and technical indicators do not suggest a compelling entry point.

Technical Analysis

The technical indicators show bearish moving averages (SMA_200 > SMA_20 > SMA_5), suggesting a downward trend. The RSI is neutral at 41.151, and MACD is above 0 but positively contracting. Support and resistance levels indicate the stock is trading near its pivot point of 11.947, with limited upside potential in the short term.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

The high Option Volume Put-Call Ratio of 5.0 indicates bearish sentiment, as there is significantly more put volume than call volume. Implied volatility is high at 86.73, with an IV percentile of 84.46, suggesting elevated uncertainty.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
8
Buy
6

Positive Catalysts

  • The company's Q1 2026 financials showed a 228.16% YoY increase in net income and a 200% YoY increase in EPS, along with an improved gross margin of 59.12%. These metrics indicate some operational improvements.

Neutral/Negative Catalysts

  • Insiders are selling heavily, with a 2417.79% increase in selling activity over the last month. Analysts have downgraded the stock due to muted growth outlooks, declining revenues, and a $77M write-down. The stock also faces ongoing demand softness and multiple headwinds in 2026.

Financial Performance

In Q1 2026, revenue dropped by 2.66% YoY to $18.42M. However, net income increased significantly by 228.16% YoY to $676K, and EPS rose by 200% YoY to 0.03. Gross margin improved to 59.12%, up 9.50% YoY, indicating better cost management.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have mixed views. TD Cowen raised the price target to $19 from $16 but maintained a Hold rating, citing potential for upside in 2026 guidance. BTIG downgraded the stock to Neutral from Buy, highlighting declining revenues, muted growth outlook, and multiple headwinds for 2026.

Wall Street analysts forecast SLP stock price to rise
5 Analyst Rating
Wall Street analysts forecast SLP stock price to rise
2 Buy
3 Hold
0 Sell
Moderate Buy
Current: 12.260
sliders
Low
19
Averages
19
High
19
Current: 12.260
sliders
Low
19
Averages
19
High
19
TD Cowen
Hold
maintain
$16 -> $19
AI Analysis
2026-01-08
Reason
TD Cowen
Price Target
$16 -> $19
AI Analysis
2026-01-08
maintain
Hold
Reason
TD Cowen raised the firm's price target on Simulations Plus to $19 from $16 and keeps a Hold rating on the shares. The firm adjusted price targets in the diagnostic tools group group as part of a Q4 preview. Investor sentiment continues to inflect upward with 2026 guidance updates "key for positioning within the sector recovery," the analyst tells investors in a research note. TD is most positive on stocks "with clear multi-year frameworks and multiple avenues for upside to derisked growth assumptions."
BTIG
Buy -> Neutral
downgrade
2025-12-18
Reason
BTIG
Price Target
2025-12-18
downgrade
Buy -> Neutral
Reason
BTIG downgraded Simulations Plus to Neutral from Buy without a price target. Despite early signs of stabilization in parts of the bio-pharma services market, Simulations Plus continues to face pressure, with declining recent revenues, a muted FY26 growth outlook, and a disappointing $77M write-down tied in part to a recent acquisition, the analyst tells investors in a research note Ongoing demand softness, limited visibility on a recovery, and multiple 2026 headwinds temper the firm's confidence in a near-term turnaround.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for SLP
Unlock Now

People Also Watch